Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02533791
What this trial is testing

A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization

Who this might be right for
Ebola Virus Disease
Jiangsu Province Centers for Disease Control and Prevention 110
Testing effectiveness (Phase 2)Looking for participantsNCT05775718
What this trial is testing

Shingrix In Recipients of Allogeneic Transplants

Who this might be right for
Bone Marrow TransplantStem Cell Transplant
University of Colorado, Denver 55
Early research (Phase 1)Study completedNCT00001096
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableUnknownNCT05126550
What this trial is testing

The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine

Who this might be right for
COVID-19
PT. Kimia Farma (Persero) Tbk 435
Testing effectiveness (Phase 2)Study completedNCT00439660
What this trial is testing

Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old

Who this might be right for
Diarrhea
Bharat Biotech International Limited 540
Early research (Phase 1)Study completedNCT06886659
What this trial is testing

Compare PK, Immunogenicity and Safety of Trastuzumab of Incepta Pharmaceuticals Ltd With Trastuzumab (Roche)

Who this might be right for
Breast CancerBreast NeoplasmsBreast Disease+1 more
Incepta Pharmaceuticals Ltd 80
Early research (Phase 1)Study completedNCT00376090
What this trial is testing

Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

Who this might be right for
HIV Infections
U.S. Army Medical Research and Development Command 48
Testing effectiveness (Phase 2)WithdrawnNCT00757926
What this trial is testing

Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants

Who this might be right for
Rotavirus Infections
Shantha Biotechnics Limited 240
Early research (Phase 1)Study completedNCT00310206
What this trial is testing

H5N1 Vaccine Intramuscular Versus Intradermal in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Study completedNCT00900991
What this trial is testing

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07666750
What this trial is testing

Safety and Immunogenicity Study of IP-QSV Vaccine in Healthy Adults/Adolescents, Children and Infants

Who this might be right for
Shigella Infection
International Vaccine Institute 370
Post-approval studies (Phase 4)Study completedNCT06189040
What this trial is testing

Immunogenicity After COVID-19 Vaccines in Adapted Schedules

Who this might be right for
Coronavirus Disease 2019COVID-19
Universiteit Antwerpen 580
Early research (Phase 1)Study completedNCT04033068
What this trial is testing

Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001)

Who this might be right for
Zika Virus Infection
Themis Bioscience GmbH 48
Testing effectiveness (Phase 2)Study completedNCT00912860
What this trial is testing

Immunogenicity and Safety Study of Serum-Free Avonex

Who this might be right for
Multiple Sclerosis
Biogen 155
Early research (Phase 1)Study completedNCT00366782
What this trial is testing

Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults

Who this might be right for
Paramyxoviridae InfectionsVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 51
Large-scale testing (Phase 3)Study completedNCT03476135
What this trial is testing

Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children

Who this might be right for
Meningococcal Infections
Sanofi Pasteur, a Sanofi Company 91
Early research (Phase 1)Ended earlyNCT02387125
What this trial is testing

Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1

Who this might be right for
SarcomaMelanomaNon-small Cell Lung Cancer+1 more
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 79
Large-scale testing (Phase 3)Looking for participantsNCT07614776
What this trial is testing

Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular DegenerationnAMD
Amgen 304
Early research (Phase 1)Study completedNCT01995617
What this trial is testing

Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine

Who this might be right for
Streptococcus Pneumoniae
Genocea Biosciences, Inc. 90
Early research (Phase 1)Study completedNCT04362410
What this trial is testing

Tezepelumab Phase 1 PK Study in Healthy Chinese Subjects

Who this might be right for
Healthy Subjects
AstraZeneca 48
Next Page